<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P1132>	<http://www.wikidata.org/entity/statement/Q98604132-5F816DF6-B9A5-47EA-8D78-9471D960301F> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P2899>	<http://www.wikidata.org/entity/statement/Q98604132-8C3A07C5-F374-4306-9341-362CFCA68C8C> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.w3.org/2000/01/rdf-schema#label>	"A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS\u00AE 250/50 Inhalation Powder/GSK in Healthy Volunteers"@nl .
<http://www.wikidata.org/entity/Q98604132>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS\u00AE 250/50 Inhalation Powder/GSK in Healthy Volunteers"@en .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P31>	<http://www.wikidata.org/entity/statement/Q98604132-F1EC2306-9923-4CBD-93AD-BA1F183A3BD9> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P4844>	<http://www.wikidata.org/entity/statement/Q98604132-D91FE2B7-557D-4CEF-8075-75BB8606257B> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P8363>	<http://www.wikidata.org/entity/Q78089383> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P4844>	<http://www.wikidata.org/entity/statement/Q98604132-B61357B2-D0D6-4CCB-9FE6-72FB06B7997E> .
<http://www.wikidata.org/entity/Q98604132>	<http://schema.org/name>	"A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS\u00AE 250/50 Inhalation Powder/GSK in Healthy Volunteers"@nl .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P6099>	<http://www.wikidata.org/entity/Q5452194> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.w3.org/2000/01/rdf-schema#label>	"A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS\u00AE 250/50 Inhalation Powder/GSK in Healthy Volunteers"@en .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P921>	<http://www.wikidata.org/entity/Q27264747> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P582>	"2020-09-30T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q98604132>	<http://schema.org/name>	"A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS\u00AE 250/50 Inhalation Powder/GSK in Healthy Volunteers"@en .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P6099>	<http://www.wikidata.org/entity/statement/Q98604132-0806A06D-902A-4A80-B37F-A2046D58EF80> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P582>	<http://www.wikidata.org/entity/statement/Q98604132-B87D7F05-50FB-4E81-BA80-D612034F204B> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P921>	<http://www.wikidata.org/entity/statement/Q98604132-ECB9319B-0F50-4969-8C00-FD08BA870C5B> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P580>	"2020-07-01T00:00:00Z"^^<http://www.w3.org/2001/XMLSchema#dateTime> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P580>	<http://www.wikidata.org/entity/statement/Q98604132-6F0A7A5D-11BF-421C-85C8-E20F6AA18CF9> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P4135>	<http://www.wikidata.org/entity/statement/Q98604132-3022A1A4-E4B7-4762-BD0E-505D3E03FED6> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P4135>	"60"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P17>	<http://www.wikidata.org/entity/Q41> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P1476>	<http://www.wikidata.org/entity/statement/Q98604132-8B2C48AF-572A-45D7-87A2-1F0E13F2DA4F> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P3098>	<http://www.wikidata.org/entity/statement/Q98604132-A1D9A0C6-6504-4B52-AF11-75D65CAC6AF6> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P4844>	<http://www.wikidata.org/entity/Q1002165> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P8363>	<http://www.wikidata.org/entity/statement/Q98604132-4C4F02C8-A550-4EDC-8F9E-CF13804C790E> .
<http://www.wikidata.org/entity/Q98604132>	<http://schema.org/description>	"ensayo cl\u00EDnico"@es .
<http://www.wikidata.org/entity/Q98604132>	<http://schema.org/description>	"clinical trial"@en .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P2899>	"18"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P31>	<http://www.wikidata.org/entity/Q30612> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P1132>	"34"^^<http://www.w3.org/2001/XMLSchema#decimal> .
<http://www.wikidata.org/entity/Q98604132>	<http://schema.org/description>	"\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P17>	<http://www.wikidata.org/entity/statement/Q98604132-FF33897C-2599-40AD-9568-F65885500C49> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P3098>	"NCT04466176" .
<http://www.wikidata.org/entity/Q98604132>	<http://schema.org/description>	"ensayu cl\u00EDnicu"@ast .
<http://www.wikidata.org/entity/Q98604132>	<http://schema.org/description>	"klinisch onderzoek"@nl .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P1476>	"A Pivotal, Randomized, Single-dose, Open Label, Two-treatment, Two-sequence, Two-period, Crossover Study Under Fasting Conditions to Examine the Bioequivalence Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS\u00AE 250/50 Inhalation Powder/GSK in Healthy Volunteers"@en .
<http://www.wikidata.org/entity/Q98604132>	<http://www.w3.org/2004/02/skos/core#prefLabel>	"A Pivotal Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS\u00AE 250/50 Inhalation Powder/GSK in Healthy Volunteers"@nl .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P4844>	<http://www.wikidata.org/entity/Q27264747> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/P8005>	<http://www.wikidata.org/entity/statement/Q98604132-1D99ADC9-ED48-45F4-8469-5CD8C327F17D> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://wikiba.se/ontology#Item> .
<http://www.wikidata.org/entity/Q98604132>	<http://www.wikidata.org/prop/direct/P8005>	<http://www.wikidata.org/entity/Q76649790> .